Skip to Main Content

INFORMATION FOR

Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.

Conditions

Mental Health & Behavioral Research

What is the purpose of this trial?

This study aims to investigate the effects of oral psilocybin on OCD symptomatology and provide the first evidence of the neural mechanism that may mediate psilocybin's purported therapeutic effects on OCD.

  • Trial with
    YCCI Pilot Project Grant
  • Start Date
    09/13/2017
  • End Date
    07/31/2023

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

  • Last Updated
    11/11/2022
  • Study HIC
    #2000020355